{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:04:41Z","timestamp":1790017481540,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,2,10]],"date-time":"2005-02-10T00:00:00Z","timestamp":1107993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,2,10]],"date-time":"2005-02-10T00:00:00Z","timestamp":1107993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2005,4,1]]},"DOI":"10.1038\/sj.gt.3302442","type":"journal-article","created":{"date-parts":[[2005,2,10]],"date-time":"2005-02-10T10:10:02Z","timestamp":1108030202000},"page":"617-624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1 gene reduces corneal neovascularization in an in vivo rabbit model"],"prefix":"10.1038","volume":"12","author":[{"given":"K C","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Y","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B J","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S W","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-G","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K K","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,2,10]]},"reference":[{"key":"BF3302442_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"JH Chang","year":"2001","unstructured":"Chang JH, Gabison EE, Kato T, Azar DT . Corneal neovascularization. Curr Opin Ophthalmol 2001; 12: 242\u2013249.","journal-title":"Curr Opin Ophthalmol"},{"key":"BF3302442_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27\u201331.","journal-title":"Nat Med"},{"key":"BF3302442_CR3","first-page":"2498","volume":"40","author":"Z Duenas","year":"1999","unstructured":"Duenas Z et al. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules. Invest Ophthalmol Vis Sci 1999; 40: 2498\u20132505.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF3302442_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0163-7258(94)90027-2","volume":"63","author":"W Auerbach","year":"1994","unstructured":"Auerbach W, Auerbach R . Angiogenesis inhibition: a review. Pharmacol Ther 1994; 63: 265\u2013311.","journal-title":"Pharmacol Ther"},{"key":"BF3302442_CR5","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1126\/science.1694043","volume":"248","author":"MA Moses","year":"1990","unstructured":"Moses MA, Sudhalter J, Langer R . Identification of an inhibitor of neovascularization from cartilage. Science 1990; 248: 1408\u20131410.","journal-title":"Science"},{"key":"BF3302442_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0002-9394(14)70868-2","volume":"124","author":"R Casey","year":"1997","unstructured":"Casey R, Li WW . Factors controlling ocular angiogenensis. Am J Ophthalmol 1997; 124: 521\u2013529.","journal-title":"Am J Ophthalmol"},{"key":"BF3302442_CR7","first-page":"S832","volume":"41","author":"HC Lin","year":"2000","unstructured":"Lin HC et al. Endostatin localization in the cornea. Invest Ophthalmol Vis Sci 2000; 41: S832.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF3302442_CR8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/archopht.120.8.1063","volume":"120","author":"BK Ambati","year":"2002","unstructured":"Ambati BK et al. Angiostatin inhibits and regresses corneal neovascularization. Arch Ophthalmol 2002; 120: 1063\u20131068.","journal-title":"Arch Ophthalmol"},{"key":"BF3302442_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00417-002-0591-7","volume":"241","author":"PC Wu","year":"2003","unstructured":"Wu PC et al. Inhibition of experimental angiogenesis of cornea by somatostatin. Graefes Arch Clin Exp Ophthalmol 2003; 241: 63\u201369.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BF3302442_CR10","first-page":"2378","volume":"41","author":"A Shafiee","year":"2000","unstructured":"Shafiee A et al. Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1. Invest Ophthalmol Vis Sci 2000; 41: 2378\u20132388.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF3302442_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/CS20020314","volume":"104","author":"JW Bainbridge","year":"2003","unstructured":"Bainbridge JW, Mistry AR, Thrasher AJ, Ali RR . Gene therapy for ocular angiogenesis. Clin Sci (London) 2003; 104: 561\u2013575.","journal-title":"Clin Sci (London)"},{"key":"BF3302442_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000072143","volume":"35","author":"WZ Yu","year":"2003","unstructured":"Yu WZ et al. Gene transfer of kringle 5 of plasminogen by electroporation inhibits corneal neovascularization. Ophthalmic Res 2003; 35: 239\u2013246.","journal-title":"Ophthalmic Res"},{"key":"BF3302442_CR13","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1038\/sj.onc.1201542","volume":"15","author":"H Nishimori","year":"1997","unstructured":"Nishimori H et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 1997; 15: 2145\u20132150.","journal-title":"Oncogene"},{"key":"BF3302442_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0169-328X(01)00004-3","volume":"87","author":"JT Koh","year":"2001","unstructured":"Koh JT et al. Characterization of mouse brain-specific angiogenesis inhibitor 1 (BAI1) and phytanoyl-CoA alpha-hydroxylase-associated protein 1, a novel BAI1-binding protein. Mol Brain Res 2001; 87: 223\u2013237.","journal-title":"Mol Brain Res"},{"key":"BF3302442_CR15","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/00004647-200209000-00003","volume":"22","author":"HJ Kee","year":"2002","unstructured":"Kee HJ et al. Expression of brain-specific angiogenesis inhibitor 2 (BAI2) in normal and ischemic brain: involvement of BAI2 in the ischemia-induced brain angiogenesis. J Cereb Blood Flow Metab 2002; 22: 1052\u20131067.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BF3302442_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.yexcr.2003.11.008","volume":"294","author":"JT Koh","year":"2004","unstructured":"Koh JT et al. Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking \u03b1v\u03b25 integrin. Exp Cell Res 2004; 294: 172\u2013184.","journal-title":"Exp Cell Res"},{"key":"BF3302442_CR17","first-page":"1809","volume":"62","author":"HM Ko","year":"2002","unstructured":"Ko HM et al. Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. Cancer Res 2002; 62: 1809\u20131814.","journal-title":"Cancer Res"},{"key":"BF3302442_CR18","first-page":"274","volume":"38","author":"U Benelli","year":"1997","unstructured":"Benelli U, Ross JR, Nardi M, Klintworth GK . Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest Ophthalmol Vis Sci 1997; 38: 274\u2013282.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF3302442_CR19","first-page":"2510","volume":"42","author":"AM Joussen","year":"2001","unstructured":"Joussen AM et al. Inhibition of inflammatory corneal aniogenensis by TNP-470. Invest Ophthalmol Vis Sci 2001; 42: 2510\u20132516.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF3302442_CR20","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/archopht.1983.01040010640024","volume":"101","author":"K Phillips","year":"1983","unstructured":"Phillips K et al. Effect of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization. Arch Ophthalmol 1983; 101: 640\u2013643.","journal-title":"Arch Ophthalmol"},{"key":"BF3302442_CR21","first-page":"1588","volume":"30","author":"WL Hayness","year":"1989","unstructured":"Hayness WL, Proia AD, Klintworth GK . Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest Ophthalmol Vis Sci 1989; 30: 1588\u20131593.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF3302442_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s004170050106","volume":"236","author":"FE Kruse","year":"1998","unstructured":"Kruse FE et al. Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor. Graefes Arch Clin Exp Ophthalmol 1998; 236: 461\u2013466.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BF3302442_CR23","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s004170050387","volume":"237","author":"AM Joussen","year":"1999","unstructured":"Joussen AM, Kruse FE, Volcker HE, Kirchhof B . Topical application of methotrexate for inhibition of corneal angiogenesis. Graefes Arch Clin Exp Ophthalmol 1999; 237: 920\u2013927.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BF3302442_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/00003226-200201000-00014","volume":"21","author":"N Kobayashi","year":"2002","unstructured":"Kobayashi N et al. Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea 2002; 21: 62\u201367.","journal-title":"Cornea"},{"key":"BF3302442_CR25","first-page":"1647","volume":"6","author":"MJ Gorrin-Rivas","year":"2000","unstructured":"Gorrin-Rivas MJ et al. Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis. Clin Cancer Res 2000; 6: 1647\u20131654.","journal-title":"Clin Cancer Res"},{"key":"BF3302442_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/sj.cgt.7700147","volume":"7","author":"KM Matsuda","year":"2000","unstructured":"Matsuda KM et al. A novel strategy for tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminigen by protease gene transfer. Cancer Gene Ther 2000; 7: 589\u2013596.","journal-title":"Cancer Gene Ther"},{"key":"BF3302442_CR27","first-page":"1975","volume":"42","author":"S Stechschulte","year":"2001","unstructured":"Stechschulte S et al. Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sci 2001; 42: 1975\u20131979.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF3302442_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/00005072-199904000-00001","volume":"58","author":"KH Plate","year":"1999","unstructured":"Plate KH . Mechanisms of angiogenesis in the brain. J Neuropathol Exp Neurol 1999; 58: 313\u2013320.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BF3302442_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng1094-171","volume":"8","author":"EG Van Meir","year":"1994","unstructured":"Van Meir EG et al. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat Genet 1994; 8: 171\u2013176.","journal-title":"Nat Genet"},{"key":"BF3302442_CR30","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","volume":"79","author":"PC Brooks","year":"1994","unstructured":"Brooks PC et al. Integrin alphav beta3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79: 1157\u20131164.","journal-title":"Cell"},{"key":"BF3302442_CR31","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1126\/science.270.5241.1500","volume":"270","author":"M Friedlander","year":"1995","unstructured":"Friedlander M et al. Definition of two angiogenic pathways by distinct alphav integrins. Science 1995; 270: 1500\u20131502.","journal-title":"Science"},{"key":"BF3302442_CR32","doi-asserted-by":"publisher","first-page":"9764","DOI":"10.1073\/pnas.93.18.9764","volume":"93","author":"M Friedlander","year":"1996","unstructured":"Friedlander M et al. Involvement of integrins alphav beta3 and alphav beta5 in ocular neovascular diseases. Proc Natl Acad Sci USA 1996; 93: 9764\u20139769.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302442_CR33","first-page":"712","volume":"60","author":"A Erdreich-Epstein","year":"2001","unstructured":"Erdreich-Epstein A et al. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. Cancer Res 2001; 60: 712\u2013721.","journal-title":"Cancer Res"},{"key":"BF3302442_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0014-5793(03)00967-0","volume":"553","author":"H Kook","year":"2003","unstructured":"Kook H et al. Nitric oxide-dependent cytoskeletal changes and inhibition of endothelial cell migration contribute to the suppression of angiogenesis by RAD50 gene transfer. FEBS Lett 2003; 553: 56\u201362.","journal-title":"FEBS Lett"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302442","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:04:12Z","timestamp":1648613052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,10]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,4,1]]}},"alternative-id":["BF3302442"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302442","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,10]]},"assertion":[{"value":"16 April 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}